Sprint Bioscience AB Capital Reinvestment Ratio
Sprint Bioscience AB capital reinvestment ratio. Sprint Bioscience AB (SPRINT) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow (Skr115.84 Million) in capital expenditures (Skr65.00K). Check Sprint Bioscience AB total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sprint Bioscience AB (2015–2025)
Capital reinvestment ratio of Sprint Bioscience AB from 2015 to 2025. This chart tracks Sprint Bioscience AB's Capital Reinvestment Ratio across 4 annual periods. Also explore Sprint Bioscience AB (SPRINT) equity growth momentum to track the company's year-over-year net asset growth rate.
Sprint Bioscience AB Capital Reinvestment Ratio by Year (2015–2025)
Sprint Bioscience AB capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see SPRINT cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | Skr83.53 Million | Skr94.00K | ▼ -99.0% |
| 2023 | 0.11x | Skr22.87 Million | Skr2.45 Million | ▼ -91.4% |
| 2016 | 1.25x | Skr7.93 Million | Skr9.91 Million | ▼ -83.2% |
| 2015 | 7.43x | Skr833.54K | Skr6.19 Million | — |